APA (7th ed.) Citation

IS, H., TY, L., R, D., S, G., BM, B., TC, S., . . . JA, J. (2014). Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate. Clinical pharmacology and therapeutics, 96(2), 175. https://doi.org/10.1038/clpt.2014.62

Chicago Style (17th ed.) Citation

IS, Hamadeh, et al. "Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate." Clinical Pharmacology and Therapeutics 96, no. 2 (2014): 175. https://doi.org/10.1038/clpt.2014.62.

MLA (9th ed.) Citation

IS, Hamadeh, et al. "Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate." Clinical Pharmacology and Therapeutics, vol. 96, no. 2, 2014, p. 175, https://doi.org/10.1038/clpt.2014.62.